genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Neuroscience
Deep Sleep Aids in Neurodegenerative Disease Prevention
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Musculoskeletal Disorders
Musculoskeletal Disorders
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Musculoskeletal Disorders
Muscular Dystrophy Condition in Mice Reversed by RNA-Targeting Cas9
Musculoskeletal Disorders
Core Set of Muscle-Building Genes Identified through Novel Human Study
Musculoskeletal Disorders
Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis, Sarepta
Musculoskeletal Disorders
Gene Therapy in Mice Builds Muscle, Staves off Obesity, and Reduces Osteoarthritis Pain
Musculoskeletal Disorders
Fruit Compound Reduces and Helps Repair Damage in MS Models
Musculoskeletal Disorders
Roche Buys Ex-U.S. Rights to Sarepta DMD Gene Therapy Candidate SRP-9001...
Musculoskeletal Disorders
FDA Places Another Clinical Hold on Trial for Solid’s DMD Gene...
Musculoskeletal Disorders
FDA Places Partial Clinical Hold on Some Trials of Novartis Gene...
Musculoskeletal Disorders
Acorda Axing 25% of Workforce, Slashing R&D Spending
Musculoskeletal Disorders
Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise
Musculoskeletal Disorders
AveXis Turns to Catalent’s Paragon for Additional Gene Therapy Manufacturing Capacity
Musculoskeletal Disorders
Vertex Grows Gene Editing Presence, Acquiring Exonics and Expanding CRISPR Therapeutics...
Musculoskeletal Disorders
Impaired Cell Communication Triggers Fat Cell Accumulation in Genetic Muscle Disease
Musculoskeletal Disorders
New Muscle Disease Caused by Mutation in Myoglobin Gene
Musculoskeletal Disorders
Sarepta to Acquire Myonexus for $165M, Broadening Muscular Dystrophy Gene Therapy...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-324x160.jpg "Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise")
